Lung Cancer
Volume 64, Issue 2 , Pages 211-218 , May 2009

Malignant peritoneal mesothelioma—Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent

  • G. Carteni

      Affiliations

    • Cardarelli Hospital, Medical Oncology, Via Cardarelli 9, 80100 Naples, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0817472221; fax: +39 0817472221.
    • ,
  • C. Manegold

      Affiliations

    • Heidelberg University Medical Center, Surgery-Interdisciplinary Thoracic Oncology, Mannheim, Germany
    • ,
  • G. Martin Garcia

      Affiliations

    • University Hospital of Salamanca, Medical Oncology, Salamanca, Spain
    • ,
  • S. Siena

      Affiliations

    • Ospedale Niguarda Ca’ Granda, Divisone Oncologia Falck, Milan, Italy
    • ,
  • C.C. Zielinski

      Affiliations

    • Department of Medicine I, Medical University, Vienna, Austria
    • ,
  • D. Amadori

      Affiliations

    • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Comitato Medico-Scientifico, Meldola, Italy
    • ,
  • Y. Liu

      Affiliations

    • i3 Statprobe, Biostatistics, Austin, TX, USA
    • ,
  • J. Blatter

      Affiliations

    • Eli Lilly and Company, Medical Oncology, Bad Homburg, Germany
    • ,
  • C. Visseren-Grul

      Affiliations

    • Eli Lilly and Company, Medical Oncology, Houten, The Netherlands
    • ,
  • R. Stahel

      Affiliations

    • University Hospital, Clinic and Policlinic of Oncology, Zurich, Switzerland

Received 25 April 2008 ,Revised 7 July 2008 ,Accepted 22 August 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(08)00459-5

doi: 10.1016/j.lungcan.2008.08.013

Lung Cancer
Volume 64, Issue 2 , Pages 211-218 , May 2009

Article Tools

* Image Usage & Resolution